[
    [
        {
            "time": "2023-10-18",
            "original_text": "“中国自主创新药的高价值链赋能”论坛今召开",
            "features": {
                "keywords": [
                    "中国",
                    "自主创新药",
                    "高价值链",
                    "论坛"
                ],
                "sentiment_score": 0.7,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "“中国自主创新药的高价值链赋能”论坛今召开",
                "Correlation": 4,
                "Sentiment": 5,
                "Importance": 6,
                "Impact": 4,
                "Duration": 5,
                "Entity_Density": 1,
                "Market_Scope": 8,
                "Time_Proximity": 9,
                "Headline_Structure": 6,
                "Source_Recency": 9
            }
        },
        {
            "time": "2023-10-18",
            "original_text": "贝莱德减持泰格医药(03347)1.79万股，每股作价约163.25港元 减持股份",
            "features": {
                "keywords": [
                    "贝莱德",
                    "减持",
                    "泰格医药",
                    "1.79万股",
                    "163.25港元"
                ],
                "sentiment_score": -0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "贝莱德减持泰格医药(03347)1.79万股，每股作价约163.25港元 减持股份",
                "Correlation": 9,
                "Sentiment": 3,
                "Importance": 7,
                "Impact": 7,
                "Duration": 5,
                "Entity_Density": 8,
                "Market_Scope": 3,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "2023-10-18",
            "original_text": "【权益变动】泰格医药(03347.HK)被NINETY ONE UK LIMITED减持7900股 减持股份",
            "features": {
                "keywords": [
                    "权益变动",
                    "泰格医药",
                    "NINETY ONE UK LIMITED",
                    "减持",
                    "7900股"
                ],
                "sentiment_score": -0.5,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "【权益变动】泰格医药(03347.HK)被NINETY ONE UK LIMITED减持7900股 减持股份",
                "Correlation": 9,
                "Sentiment": 3,
                "Importance": 6,
                "Impact": 6,
                "Duration": 4,
                "Entity_Density": 9,
                "Market_Scope": 2,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        }
    ]
]